2016 American Transplant Congress » Poster Session B: Hearts and VADs in Depth - The Force Awakens

6:00pm-7:00pm

Clostridium difficile Infection in Patients with a Continuous Flow, Durable Left Ventricular Assist Device.

J. Glick Frasiolas, I. Li, H. Kim, D. Tsapepas.

6:00pm-7:00pm

Air Pollution – An Additional Risk Factor for Developing Cardiac Allograft Vasculopathy.

C. Bara, D. Böthig, Y. Scheibner, D. Bobylev, B. Przybylek, A. Haverich.

6:00pm-7:00pm

Anti-HLA Antibody Composition and Outcomes in Pediatric Heart Transplant Recipients with a Positive Cross-Match.

P. Jindra,¹ S. Nicholas,² J. Chappelle,¹ T. Humlicek,² K. Hosek,² J. Heinle,² S. Denfield,² A. Jeewa,² R. Kerman,¹ W. Dreyer.²

6:00pm-7:00pm

Assessment of Molecular Mechanisms of Non-Transplant Cardiac Hypertrophy in Cardiac Allograft Hypertrophy – An Exploratory Gene Array Study of Myocardial Biopsy Samples.

R. Araujo-Gutiérrez,^1,2 S. Ibarra-Cortez,^1,2 M. Park,¹ J. Estep,¹ G. Ashrith,¹ B. Trachtenberg,¹ G. Torre-Amione,¹ K. Youker,^1,2 A. Bhimaraj.¹

6:00pm-7:00pm

Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.

J. Glick Frasiolas, J. Matthew, D. Tsapepas.

6:00pm-7:00pm

Calcineurin Inhibitor (CNI) Delay with ATG Induction: Teaching an Old Dog, New Tricks.

A. Aliabadi,¹ J. Goekler,¹ O. Salameh,¹ T. Haberl,¹ B. Steinlechner,² P. Opfermann,² A. Kaider,¹ K. Uyanik-Uenal,¹ G. Laufer,¹ A. Zuckermann.¹

6:00pm-7:00pm

Comparison of Actual versus Goal Tacrolimus Levels Post Cardiothoracic Transplant.

E. Milas, I. Feurer, C. Truscott, J. Gray, N. Wilson, S. Bala, T. Dreher, M. Wigger, M. Steele, A. Shah, E. Lambright, D. Hanto.

6:00pm-7:00pm

Donor-Recipient Race Matching Is Not Associated with Recipient Survival Following Heart Transplantation.

C. Evans,¹ P. Sanchez,¹ Z. Kon,¹ E. Feller,² B. Griffith,¹ S. Pham.¹

6:00pm-7:00pm

Elucidating Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation.

R. Quintana-Quezada, I. Rajapreyar, Y. Yeh, S. Choi, I. Gregoric, P. Loyalka, B. Kar.

6:00pm-7:00pm

Exosomes Expressing Cardiac Self-Antigens (Myosin and Vimentin) and Immuno-Regulatory miRNA Induce Graft Rejection.

M. Sharma,^1,2 M. Gunasekaran,^1,2 Z. Xu,^1,2 N. Steward,¹ W. Liu,^1,2 N. Benshoff,¹ T. Mohanakumar.^1,2

6:00pm-7:00pm

Four-Factor Prothrombin Complex Concentrate as a Strategy to Rapidly Reverse Anticoagulation in Patients Undergoing Cardiac Transplantation: Better Than the Conventional Approach?

T. Sam,¹ G. Gonzalez-Stawinski,² G. Saracino,³ A. Jamil,³ S. Hall,² K. Cox,¹ B. Lima.²

6:00pm-7:00pm

Gender Mismatch in the UNOS Heart Transplant Database: Not a Factor in Younger Heart Transplant Patients.

J. Kobashigawa, M. Kittleson, L. Czer, T. Aintablian, E. Passano, D. Chang, F. Esmailian, J. Patel.

6:00pm-7:00pm

Gene Expression Levels of Advanced Heart Failure Patients in Terms of Coagulation and Its Effect within Multiple Organ Dysfunction Syndrome.

R. Togashi, E. Chang, N. Wisniewski, M. Cadeiras, G. Bondar, E. Reed, M. Deng.

6:00pm-7:00pm

Gene Expression Profiling Score and the Risk of Infection in Heart Transplant Recipients.

J. Teuteberg,¹ D. Budge,² M. Shullo,¹ S. Hall,³ J. Kobashigawa.⁴

6:00pm-7:00pm

Heart and Kidney Transplants in Patients with Mechanical Circulatory Support: Who Needs a Kidney?

J. Neyer, J. Patel, M. Kittleson, D. Chang, M. Luu, T. Aintablian, E. Passano, L. Czer, F. Esmailian, J. Kobashigawa.

6:00pm-7:00pm

Impact of Donor Specific Antibodies on Cardiac Allograft Vasculopathy.

A. Vu,¹ A. Althouse,² A. Zeevi,³ J. Teuteberg,² M. Shullo.²

6:00pm-7:00pm

Impact of Transfusion Requirements on Likelihood of Heart Transplantation After Total Artificial Heart.

J. Cook,¹ L. Kang,¹ M. Flattery,² I. Tchoukina.²

6:00pm-7:00pm

Is Donor Methamphetamine Use a Contraindication in Heart Transplantation?

M. Kittleson, J. Patel, L. Czer, A. Velleca, T. Aintablian, D. Chang, F. Esmailian, J. Kobashigawa.

6:00pm-7:00pm

Liver Evaluation for Heart Transplantation: Which Is Better, Noninvasive Scans or Liver Biopsy?

R. Mohan, J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, F. Esmailian, J. Kobashigawa.

6:00pm-7:00pm

Management and Outcomes of Upper Extremity Deep Venous Thrombosis in Heart Transplant Patients.

A. Panakos,¹ D. Kramer,¹ M. McCarey,¹ P. Mather.²

6:00pm-7:00pm

Medicaid Insurance Is Associated with Shorter Time to Transplant Listing After LVAD Implantation.

W. Schultz, M. Yin, Y.-A. Ko, J. Vega, A. Morris.

6:00pm-7:00pm

Morbidity and Mortality of Early Post-Operative Acute Kidney Injury in Cardiothoracic Transplant Recipients.

J. Casale, A. Logan, C. Doligalski.

6:00pm-7:00pm

Outcome of the Various Pathology Grades of Antibody-Mediated Rejection After Heart Transplantation.

J. Patel, M. Kittleson, D. Chang, T. Aintablian, L. Czer, A. Trento, J. Kobashigawa.

6:00pm-7:00pm

Posterior Reversible Encephalopathy Syndrome After Pediatric Heart Transplantation: Increased Risk for Children with Preexisting Glenn/Fontan Physiology.

M. Kemna,¹ B. Eilers,² E. Albers,¹ Y. Law.¹

6:00pm-7:00pm

Predicting Emergence of Anti-HLA Class I and II Antibodies by Time Dependent Phenomapping in Heart Transplant Patients.

M. Bakir, N. Jackson, E. Chang, D. Henriquez-Ticas, C.-H. Tseng, T. Khuu, J. Zhang, E. Reed, M. Deng, M. Cadeiras.

6:00pm-7:00pm

Predictors of Donor Heart Utilization in United States.

J. Trivedi, A. Cheng, E. Schumer, M. Black, H. Massey, M. Slaughter.

6:00pm-7:00pm

Prednisone Wean After Dual Heart and Kidney Transplantation: Is There a Risk?

D. Chang, J. Patel, M. Kittleson, T. Aintablian, L. Czer, D. Ramzy, J. Kobashigawa.

6:00pm-7:00pm

Qualitative Assessment of Patient-Perceived Treatment Burden Following Cardiac Transplantation.

K. Deininger,¹ J. Reich,¹ J. Hirsch,² S. Graveline,² A. Feist,² J. LaFleur,³ S. Smith,⁴ A. Ambardekar,¹ J. Lindenfeld,⁵ C. Aquilante.¹

6:00pm-7:00pm

Relationship Between Changes in Brain Natriuretic Peptide Levels and Cardiac Allograft Rejection Early After Heart Transplantation.

J. Dann,¹ K. Deininger,¹ D. Reinhold,¹ R. Page II,¹ A. Ambardekar,¹ J. Lindenfeld,² C. Aquilante.¹

6:00pm-7:00pm

The Impact of Donor Origin on Survival after Orthotopic Heart Transplantation.

O. Kiamanesh, A. Khosla, C. Imai, E. Johansson, S. Virani, M. Davis, A. Cheung, J. Bashir, B. Munt, A. Ignaszewski, A. Kaan, M. Toma.

6:00pm-7:00pm

The Role of Short-Term Ventricular Assist Device in Patients with Cardiogenic Shock – Is It Really a Solution?

A. Popov, M. Zeriouh, S. Anton, W. Alexander, Z. Bartlomiej, D. Garcia, P. Mohite, A. Padukone, A. Koch, O. Ananiadou, L. Fazekas, A. Simon.

6:00pm-7:00pm

Treatment for AMR and DSA: A Center Based Review of Pediatric Orthotopic Heart Transplant Recipients.

D. Drogalis-Kim,¹ M. Hickey,² J. Alejos,¹ E. Reed,² N. Halnon.¹

6:00pm-7:00pm

Using Gastrointestinal Biopsy to Predict Outcome in Patients Evaluated for Cardiac Transplantation for Amyloidosis: A Report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT).

Y. Li,¹ K. Verkouw,¹ S. Tabtabai,¹ R. Barrios,² R. Gill,³ J. Koo,⁴ C. Marboe,⁵ E. Rodriguez,⁶ C. Tan,⁶ T. De Marco,³ J. Estep,² M. Hanna,⁶ M. Maurer,⁵ J. Patel,⁴ V. Selby,³ M. Semigran,¹ J. Stone.¹